It has been reported only that chemotherapeutic agents like docetaxel decrease intratumoral aromatase mRNA levels in breast tumors, suggesting that antitumor activity of chemotherapy is mediated, at least in part, through suppression of intratumoral estrogens synthesis (Miyoshi et al., 2004). Here, CYP19A1 is linked to breast neoplasm.